KBRA releases its 2026 European project finance and infrastructure (PF&I) Sector Outlook, examining themes that will likely take centre stage in 2026 as well as developments and ratings trends from ...

Biogen has secured European regulatory approval for a high-dose regimen of its Spinraza drug for the neuromuscular disease spinal muscular atrophy, or SMA. Biogen on Monday said the European ...

Europe's latest measures to expand domestic critical minerals supplies lack the funding tools needed to spur investment and wrestle supplies from dominant countries like China.

Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both ...

Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...

The European Commission has announced the adoption of new guidelines that set general criteria allowing it to exclude foreign companies from public procurement markets in the European Union, in a move ...

U.S. commercial launch in thalassemia underway following December 2025 FDA approvalPre-sNDA meeting with FDA for mitapivat in sickle cell disease anticipated in first quarter of 2026, with planned U.S ...

Last January, Meta CEO Mark Zuckerberg said he was eager to have an ally in the White House to go after foreign regulations ...

European law firm Fieldfisher has further strengthened its regulatory offering in the Brussels office with the arrival of ...

The European Banking Authority has clarified that current European Union banking rules prevent lenders that own asset management firms through an insurance unit from applying to the asset managers ...

Pharmaceutical drugs developed by two local companies received approvals in the European Union last month. On Dec. 12, Culver ...